Grifols is gearing up to file for approval of a drug for rare bleeding disorder acquired fibrinogen deficiency (AFD) that could provide a more reliable and easier treatment for patients.

However, in some people, the response causes excess production of fibrinogen (a protein that helps with blood clotting) and ...